Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)

Yu Ri Kim, Jin Seok Kim, Yoo Hong Min, Dok Hyunyoon, Ho Jin Shin, Yeung Chul Mun, Yong Park, Young Rok Do, Seong Hyun Jeong, Joon Seong Park, Sung Yong Oh, Suee Lee, Eun Kyung Park, Joung Soon Jang, Won Sik Lee, Hwe Won Lee, Hyeonseok Eom, Jae Sook Ahn, Jae Heon Jeong, Sun Kyung BaekSeok Jin Kim, Won Seog Kim, Cheolwon Suh

Research output: Contribution to journal › Article › peer-review

64 Scopus citations

Fingerprint

Dive into the research topics of 'Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)'. Together they form a unique fingerprint.

Medicine & Life Sciences